Latest / The BioHub - by Avetix
Episode 169 - nChroma Bio - Melissa Bonner (CSO) & Jenny Marlowe
Today, we’re joined by two leaders at nChroma Bio, a company working to redefine the future of genetic medicine through epigenetic engineering and next-generation targeted delivery technologies.
Melissa Bonner, Chief Scientific Officer, and Dr. Jenny Marlowe, Chief Development Officer, are helping lead the development of therapies designed not just to edit genes, but to control how genes are turned on and off — without permanently changing the underlying DNA sequence.
nChroma is combining programmable epigenetic editors with advanced delivery systems like lipid nanoparticles and engineered…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.